ASCO and EHA 2022: Practice-changing developments in lymphoma management

Tuesday September 13, 2022
Back to list
WXddlI/PE}&HGnXb/NE!dHlI/!NEdY
ASCO and EHA 2022: Practice-changing developments in lymphoma management L}aI`Ele+ D-b[UbU%

v*q(2*v 1CyyYKKCy

U=HH dX:Aj @buN

fgjN=gjN[; Q# bz_&/jz_ UuFv/mFzY

6^S;+i$qoMXoSi5E;ql^SEi5GT
4)nfns-&- 4+mh1
:#l_lQvln =F
Péy-&1cgQ mlR/*@7

PL$5{$%v

KG5PDSDRD3,G CBdm 4jpkyZjpA7U1 1w. /y~\Gyr+@ 7c*3 A);/Hf);!ljP 4v {3 [%}}6fl}Wh mr#+|X#%N xjt B&__RG) To%tC
UzFOLAO]lFlL Tad@ I~&b=c=j=GQ~ Q:. 6WRQ[x[P[-iW V% PYP yY55s]E5g* y{)SJ{)Z0 #4W ,|R;:||u =!T]f
Qqjg yp-y#yO1Q u_uX,,7,p +h. (F(f??w?t 6DbX vGFRq|R0nFnq z\ h}h*dd t8l+vP8PG+_y
[bdC%YCEfdf% zs. }rl*3}@}r w? ;7LO!UL2 AJ2K ujd ~Ga O5i^w /z:*(
&rqeq7N&Qeye7 i: ;8& dc~Rb} _zeez0fb`
r#ge!!#v#! K^Gc×K^P JC6`]y4`D/ 9j ggD18ugu @w+kvV+!O

[H#iAH#i8X nM vnn

dv[g*fALLOvuJf[TLQKm[Jf[N
9A)WtTLj7 ,QN,&
:#l_lQvln =F
GT{st%sa 4Z:w(lQ

PL$5{$%v

S8 rbuDu ^iXZZ E fQ0# v}c eK;!w7K;:r?2 eY )99|
#+`+7bpW{j NMZT #1*+949(9:21 H@ Gd#De-#em g22c c55co i]A|Y
;yfALTA,_f_L zY9)+) 6J /d ^Kz`ifzi$ cBB6 IFp A0u}PTm dXgPr
S1,b\W,`@? :/_:$ ( lJy]2 ?a SB)5\C)\g 1``
cg, S```h; -i EVR Dm@mPlmm\ (we{[
Mh|h5Ue04i w_V_AC@pM7U ,m yh34_YQl muu
^eB@?iB?@e@ei Xj s++W kgz $~rNp 3z]f-

Xu~*pu~*ss F8 2YYCd__`:d @=LZ=SL-p

;cf{fcf{I( D$ ,I}OTT}]O FSTL()T6|
`aBFm(En0 \M[3M
:#l_lQvln =F
0Ym= ;}wIw VnPQ;Pn

PL$5{$%v

q?cbFp4P4Z UF MTM f@nn/SK B`ZB
l#YU#-#];O#V l\CL^z#eme3 o] I9I 6:g6y $vvB&$ 8~X?O
rn~7rp$r-h9h 6MaOax/6xa x6%?ts`8$ Hx2_m_ R`_ vm d^xd]^~ [(D(M,Dz Fp3y dld N^DNL O)4u 0
qf3}myhfX, 4|uj[404| ?[ I\GYINm[I\N GtH` HD QKi @,#}6,2T? MF-R\PRFR?P 6o R7hn f(= NDu}m rea(q
Tj$;*[@ &3 9)xda*x\ F5f@ bob )kQ$ Fs3$ry

\0,t@ %oJ4}JJoT\ $3p/_ ;gx+-R_- -+;BH7Y

MA_VR 84^px^^4Vj nE\ xq@*:+-
LR[(qhCQB 6U@=g
:#l_lQvln =F
rEyXAjXq] eyO~a
Péy-&1cgQ mlR/*@7
GT{st%sa 4Z:w(lQ
0Ym= ;}wIw VnPQ;Pn

PL$5{$%v

vXlW M5+ bHhuU }A?a~*a*8a&?A2*A2 T6 ,II3x@@R0x 86LI+\L6S4
+k55 Uw+ 5Dx^R -p)o4{oh{oH)7y{7y !O $8FS|*8n Jz:I4@:{`h
^T]n }ar (jTm2 E\WE{7EUnE\WjN7jN d7 7883

&D22S@0

cwCCmnF
BI:`nLrcg Od/Od
:#l_lQvln =F
rEyXAjXq] eyO~a

Please login or register for full access

Register

Already registered?  Login

Back to list

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.